There were 2,436 press releases posted in the last 24 hours and 440,373 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Karolinska Development portfolio company Aprea Therapeutics updates clinical data from Phase Ib trial of APR-246 in ovarian cancer.

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image